This study evaluated the role of CXCL8 and LSECtin in the immune microenvironment and ICIs efficacy prediction of colon cancer, and clarified the regulatory mechanism of CXCL8 regulating LSECtin through AKT activation. The gene discussed is CXCL8; the disease is malignant colon neoplasm.